Cesarean Niche Examination by Transvaginal us

The developed uterine scar developing due to cesarean section is usually clinically evaluated and visualized by transvaginal sonography (TVS) and saline infusion sonography (SIS) or Gel installation sonography (GIS)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cesarean Section; Dehiscence

Age range

20 year–42 year

Sex eligibility

Female

Study type

Observational

Primary location

Algazeerah, Giza, Egypt

About this study

In 2015, WHO displayed and reveled a systematic review of the research studies in the scientific literature to evaluate and asses the linkage and connection between cesarean section rates and maternal

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

women with secondary infertility

Exclusion criteria

obstructed labor, pregnant women having chronic diseases;

Treatment and study plan

transvaginal us with 2D and 3D SHG

Diagnostic Test

transvaginal us is made to all women with SHG

Primary outcomes

The number of women who will have dehesent scar

Time frame: within a week

transvaginal us showing lower segment with assessing scar

Sponsors and collaborators

Lead sponsor

Aljazeera Hospital

Other

Registry information

Official study title

Cesarean Niche Examination by us to Assess Its Integrity and Dehescence

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Sep 4, 2019
Registry last updated: May 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed